0      0

AONN+ Annual 2020


SAT06 - Industry Sponsored Session | Extensive-Stage SCLC, Unresectable Stage III NSCLC, and Metastatic EGFR Mutation-Positive NSCLC (non-CE) Presentation by AstraZeneca


Nov 7, 2020 11:45am ‐ Nov 7, 2020 1:00pm

Speaker(s):

  • Beth Sandy, MSN, CRNP, Abramson Cancer Center | University of Pennsylvania

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content